Multiple myeloma is a type of blood cancer that develops in plasma cells, a type of white blood cell in your bone marrow. Treatment for multiple myeloma is important for the cancer's overall prognosis ...

Multiple myeloma is a rare type of blood cancer that starts in your plasma cells. Your plasma cells are a type of white blood cell inside your bone marrow, the soft inner part of your bones. If you ...

Women and stage 2 multiple myeloma patients report higher psychological distress at initial consultations. Non-Hispanic Black patients and those in socially vulnerable neighborhoods are less likely to ...

On Friday, Johnson & Johnson (NYSE:JNJ) released updated results from the investigational Phase 1b RedirecTT-1 study evaluating the combination of Talvey (talquetamab) and Tecvayli (teclistamab) in ...

Using nationwide electronic health record (EHR) and cancer registry data from the VA Corporate Data Warehouse, we developed and validated a rule-based NLP algorithm to extract oncologist-determined MM ...

The EXCALIBER-RRMM study evaluated the efficacy and safety of iberdomide, an investigational cereblon E3 ligase modulator, in combination with dexamethasone and daratumumab in adults with RRMM.

Stem cell transplant options have expanded, utilizing matched siblings, unrelated donors, and umbilical cord blood, enhancing access for hematologic cancer patients. October brought developments in ...

Stage 1 multiple myeloma features low beta-2 microglobulin, high albumin, and no organ damage, often detected incidentally. Diagnosis involves blood, urine, imaging tests, and bone marrow biopsy to ...

Bristol Myers Squibb BMY announced positive data from the late-stage study on iberdomide in patients with relapsed or refractory multiple myeloma (RRMM). The phase III EXCALIBER-RRMM (NCT04975997) is ...

A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. This story was originally published on BioPharma Dive. To receive daily news ...